UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment

Journal of clinical pharmacology, 2016-12, Vol.56 (12), p.1484-1499

2016

Volltextzugriff (PDF)

Expression of OATP family members in hormone-related cancers: potential markers of progression

PloS one, 2011-05, Vol.6 (5), p.e20372-e20372

2011

Volltextzugriff (PDF)

Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activome

Cancer biology & therapy, 2022-12, Vol.23 (1), p.136-138

2022

Volltextzugriff (PDF)

Genomic Characterization of Preclinical Prostate Cancer Cell Line Models

International journal of molecular sciences, 2024-06, Vol.25 (11), p.6111

2024

Volltextzugriff (PDF)

Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p

Scientific reports, 2021-05, Vol.11 (1), p.10765-11, Article 10765

2021

Volltextzugriff (PDF)

The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors

Molecular cancer therapeutics, 2009-09, Vol.8 (9), p.2496-2508

2009

Volltextzugriff (PDF)

Molecular drivers of metastatic castrate-resistant prostate cancer: New roads to resistance

Cancer biology & therapy, 2018-10, Vol.19 (10), p.869-870

2018

Volltextzugriff (PDF)

Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib

Journal of experimental & clinical cancer research, 2010-07, Vol.29 (1), p.95-95, Article 95

2010

Volltextzugriff (PDF)

Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA) n Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors?

International journal of molecular sciences, 2020-01, Vol.21 (3), p.896

2020

Volltextzugriff (PDF)

Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers

Scientific reports, 2021-03, Vol.11 (1), p.5662-5662, Article 5662

2021

Volltextzugriff (PDF)

PARP Inhibitors and Prostate Cancer: To Infinity and Beyond BRCA

The oncologist (Dayton, Ohio), 2021-01, Vol.26 (1), p.e115-e129

2021

Volltextzugriff (PDF)

Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial

PloS one, 2015-05, Vol.10 (5), p.e0126672-e0126672

2015

Volltextzugriff (PDF)

Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx

Molecular cancer research, 2017-08, Vol.15 (8), p.1096-1105

2017

Volltextzugriff (PDF)

Pharmacogenetics and Regulation of Human Cytochrome P450 1B1: Implications in Hormone-Mediated Tumor Metabolism and a Novel Target for Therapeutic Intervention

Molecular cancer research, 2006-03, Vol.4 (3), p.135-150

2006

Volltextzugriff (PDF)

Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients

BMC cancer, 2010-09, Vol.10 (1), p.511-511, Article 511

2010

Volltextzugriff (PDF)

Disclosing a Diagnosis of Cancer: Where and How Does It Occur?

Journal of clinical oncology, 2010-08, Vol.28 (22), p.3630-3635

2010

Volltextzugriff (PDF)

A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer

BJU international, 2008-09, Vol.102 (5), p.617-621

2008

Volltextzugriff (PDF)

Sarcosine as a potential prostate cancer biomarker and therapeutic target

Cancer biology & therapy, 2010-03, Vol.9 (5), p.341-342

2010

Volltextzugriff (PDF)

Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer

Cancer biology & therapy, 2010-07, Vol.10 (1), p.13-18

2010

Volltextzugriff (PDF)

Alam K et al. (2018) Drug Metabolism Letters; 12, 24-32

Drug metabolism letters, 2018, Vol.12 (2), p.153-153

2018

Volltextzugriff (PDF)

Androgen receptor variation affects prostate cancer progression and drug resistance

Pharmacological research, 2016-12, Vol.114, p.152-162

2016

Volltextzugriff (PDF)

Significant addition to treatment options for bone metastasis in prostate cancer

Cancer biology & therapy, 2012-01, Vol.13 (2), p.69-70

2012

Volltextzugriff (PDF)

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population

Prostate cancer and prostatic diseases, 2019-09, Vol.22 (3), p.406-410

2019

Volltextzugriff (PDF)

Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models

Molecular cancer therapeutics, 2021-05, Vol.20 (5), p.915-924

2021

Volltextzugriff (PDF)

Influence of Genetic Variants in UGT1A1 and UGT1A9 on the In Vivo Glucuronidation of SN-38

Journal of clinical pharmacology, 2004-08, Vol.44 (8), p.854-860

2004

Volltextzugriff (PDF)

1 – 25 von 393

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Cancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(364)
Mit Volltextzugriff
(327)

Publikationsform

Sprache

Englisch
(391)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Biology & Therapy
(34)
Journal Of Clinical Oncology
(17)
Cancer Research
(10)
Molecular Cancer Therapeutics
(8)
Nature
(8)
The Journal Of Urology
(8)
Journal Of The American College Of Cardiology
(7)
Nature Genetics
(6)
Rheumatology
(6)
Genomics
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment

Expression of OATP family members in hormone-related cancers: potential markers of progression

Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activome

Genomic Characterization of Preclinical Prostate Cancer Cell Line Models

Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p

The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors

Molecular drivers of metastatic castrate-resistant prostate cancer: New roads to resistance

Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib

Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA) n Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors?

Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers

PARP Inhibitors and Prostate Cancer: To Infinity and Beyond BRCA

Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial

Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx

Pharmacogenetics and Regulation of Human Cytochrome P450 1B1: Implications in Hormone-Mediated Tumor Metabolism and a Novel Target for Therapeutic Intervention

Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients

Disclosing a Diagnosis of Cancer: Where and How Does It Occur?

A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer

Sarcosine as a potential prostate cancer biomarker and therapeutic target

Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer

Alam K et al. (2018) Drug Metabolism Letters; 12, 24-32

Androgen receptor variation affects prostate cancer progression and drug resistance

Significant addition to treatment options for bone metastasis in prostate cancer

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population

Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models

Influence of Genetic Variants in UGT1A1 and UGT1A9 on the In Vivo Glucuronidation of SN-38

Aktive Filter

Suchergebnisse filtern